Summit Logo
  UPDATE 5 
September 11, 2012 
BIO
Gillian Mullins
Ms. Gillian Mullins 
Farrington Profile
Mr. Thomas A. Farrington
Janice King 
Dr. Janice King 
Thomas Sellers
    Mr. Thomas P. Sellers     

Industry Panel
Astellas
BN Immuno
Dendreon
Janssen


Summit 
Information


Summit
 Registration

 

 

Hyatt Regency Washington 
 Capitol Hill 
*Please Register Now*
 

 

The Summit is Free and Open to the Public
 
   
 
Like us on Facebook
Like Us 
Follow us on Twitter
Follow Us 
View our videos on YouTube View Our Videos 

Prostate Cancer Roundtable

SESSION HIGHLIGHTS
Friday, September 21st
9:00 AM - 12:00 PM 
Biotechnology Industry Organization
1201 Maryland Ave., SW
Suite 900
Washington DC

  

Session IV: Industry Action
 
This session will examine industry actions to address the prostate cancer disparity through new treatments and educational outreach. An overview of the treatment development process from the laboratory to the patient, outlining the important role of patient participation in clinical trials, followed by an industry panel presentation and discussion will be featured.
  
                           ***************        
SESSION IV
Welcome: 
Ms. Gillian Mullins, Managing Dir. of Alliance Development, Biotechnology Industry Organization 
 
Remarks and Session Overview: 
Mr. Thomas A. Farrington, PHEN President and Founder 
 
Understanding the Prostate Cancer Treatment Development Process: 
Janice King, PhD, Senior Medical Science Liaison, Astellas/Medivation
 
Industry Panel Presentations and Discussions 
Moderator: Thomas P. Sellers, Senior Director, Patient Advocacy and Corporate Philanthropy, Millennium: The Takeda Oncology Company
Presenters:
Astellas/Medivation: Janice King, PhD, Senior Medical Science Liaison  
BN Immunotherapeutics: Olga Bandman, MD, Medical Director 
Dendreon: Mr. Joe I. DePinto, Executive Vice President, Global Commercial Operations
Janssen Pharmaceuticals: Ms. Lisa Vaga, 
Director of Communications 
 
Q & A

Summit Closing Remarks: 
Mr. Thomas A. Farrington, PHEN President and Founder 

                                    *************** 
Background
Session IV
PHEN and biopharmaceutical organizations partner in support of PHEN's "Rally Against Prostate Cancer (RAP Cancer)" initiatives, and advocacy efforts towards accelerated development and access to new treatments. RAP Cancer addresses the African American prostate cancer crisis through education and awareness outreach to men and their families, with an emphasis on increasing knowledge about clinical trials and treatment options.

This summit session will provide important and useful insights and information for those organizations seeking partnerships and support for clinical trials recruitment and community outreach, and for patients and advocacy organizations.
 
                                      *************** 
Thursday Summit Schedule and Program Highlights 

Thursday, September 20
8:30 AM - 1:15 PM 
Kennedy Caucus Room
Room 325 
Russell Senate Office Building 
Constitution Avenue and 1st Street, N.E., Washington D.C. 
 
**Lunch Will be Provided**
 
Thursday September 20
2:00 PM - 4:30 PM 
Community Action 
New Samaritan Baptist Church 
1100 Florida Avenue, N.E., Washington D.C. 
(Travel provided via bus to New Samaritan Church)
 
                             ***************
SEPTEMBER IS PROSTATE CANCER AWARENESS MONTH

PHEN's September monthly meeting and webcast will celebrate with an in-depth review of the "Eighth Annual African American Prostate Cancer Disparity Summit"

6 PM ET
(Webcast Link will be live at 6 pm ET)